HH

Hartford HealthCare Endowment

North America, Connecticut, United States, Hartford

Description

Hartford HealthCare Endowment is a healthcare investment firm that offers behavioral, pain treatment, weight loss, and other care services.

Investor Profile

Hartford HealthCare Endowment has made 8 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (63%)
  • Series D (25%)
  • Series C (13%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Life Science
  • Medical
  • Clinical Trials
  • Health Diagnostics
  • Biopharma
  • Big Data
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Hartford HealthCare Endowment frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 3
StepStone Group
North America, New York, United States, New York
Co-Investments: 2
Nextech Invest
Europe, Zurich, Switzerland, Zürich
Co-Investments: 2
EC
North America, New York, United States, New York
Co-Investments: 3
UI
North America, California, United States, Oakland
Co-Investments: 2
Casdin Capital
North America, New York, United States, New York
Co-Investments: 3
Horizons Ventures
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 2
The Column Group
North America, California, United States, San Francisco
Co-Investments: 6
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 2
Lux Capital
North America, New York, United States, New York
Co-Investments: 2

Which angels does Hartford HealthCare Endowment often collaborate with?

BG
North America, Washington, United States, Seattle
Shared Deals: 1

What are some of recent deals done by Hartford HealthCare Endowment?

Axuall

Cleveland, Ohio, United States

Axuall is a workforce intelligence company providing data and insights for network planning, analytics, and credentialing for healthcare.

Big DataDatabaseHealth CareInformation Technology
Series BMay 31, 2023
Amount Raised: $20,000,000
Kallyope

New York, New York, United States

Kallyope uses the science of gut-brain biology to create medicines that transform human health.

BiotechnologyHealth CareMedicalPharmaceutical
Series DFeb 15, 2022
Amount Raised: $236,000,000
Eikon Therapeutics

Hayward, California, United States

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

BiotechnologyHealth CareLife ScienceMedical
Series BJan 6, 2022
Amount Raised: $518,000,000
Circle Pharma

San Francisco, California, United States

Circle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides.

BiotechnologyClinical TrialsHealth CareTherapeutics
Series CJun 16, 2021
Amount Raised: $66,000,000
Janux Therapeutics

La Jolla, California, United States

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

BiotechnologyHealth DiagnosticsPharmaceuticalTherapeutics
Series BApr 20, 2021
Amount Raised: $125,000,000
A2 Biotherapeutics

Agoura Hills, California, United States

A2 Biotherapeutics is an early-stage biotechnology company that develops medicines for serious illnesses.

BiotechnologyHealth CareLife Science
Series BOct 6, 2020
Amount Raised: $71,500,000
ORIC Pharmaceuticals

South San Francisco, California, United States

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics
Series DAug 9, 2019
Amount Raised: $55,000,000
Surrozen

South San Francisco, California, United States

Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.

BiotechnologyEmergency MedicineHealth Care
Series BMar 15, 2019
Amount Raised: $50,000,000